A survey instrument, using Likert-scale items, was developed to measure EOL care processes (assessment, delivery, communication among providers, communication with residents/families) and organizational structure in NHs. Also included were items such as turnover, staffing, and facility characteristics. 608 surveys were mailed to all facilities in New York State; 313 were completed (52.4%).
Cronbach's alphas, Pearson's correlations, and regression models were used to assess the reliability and validity of the instrument. Multivariate regressions, with random effects, were used to examine predictors of better EOL processes.
Cronbach's alphas, ranging from 0.63 to 0.82 demonstrate moderate-to-high reliability for process domains. Regression models demonstrate statistically significant relationships between process domains and structural variables. Presence of quality assurance mechanisms and EOL in-service education for nursing staff, are consistently and significantly (p<0.05) associated with better care processes. Management turnover is negatively and significantly associated with assessment (p=0.0001), delivery (p=0.041), and communication with residents/families (p=0.017). Facilities with religious affiliation have higher scores for communication with residents/families (p=0.042).
We developed and tested the reliability and validity of an instrument to measure EOL care processes in NHs. Our findings provide insights for NH leaders striving to improve EOL care processes and ultimately the quality of care for dying residents.
Learning Objectives:
1. Evaluate reliability and validity of an instrument measuring EOL care processes.
2. Examine factors associated with better care.
3. Identify modifiable management practices associated with better EOL care.
Keywords: End-of-Life Care, Nursing Homes
Qualified on the content I am responsible for because: this abstract represent my own work
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
![[ Visit Client Website ]](images/banner.gif)